FTO and leukemia: Although all FTO knockdown clones displayed significant and dose-dependent decreases of cell viability, the scrambled clones could proliferate at drug concentrations much larger than the IC50 value, in agreement with our previous findings (36) that FTO positively regulates TKI sensitivity in leukemia cells.